🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This pilot study tests the hypothesis that the medication nitric oxide extr...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2017-11-01
Trial ID
NCT02653833
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The study proposes to assess the effect of multiple applications of antimic...
Status
Completed
Location
Mariana Sales
Start Date
2014-09-01
Trial ID
NCT03039244
Treatments Being Tested
assess and compare the efficacy of pericapsular nerve group block wersus lu...
Status
Completed
Location
Aculty of Medicine,Zagazig University
Start Date
2021-06-01
Trial ID
NCT04899388
Treatments Being Tested
The aim of the study is to determine the effectiveness of nebulized azithro...
Status
Completed
Location
Alexandria University
Start Date
2024-10-02
Trial ID
NCT06584474
Treatments Being Tested
Shared decision making is the first overarching principle for the treat to ...
Status
Completed
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2022-09-19
Trial ID
NCT05530694
Treatments Being Tested
The primary specific aim is to perform a randomized controlled trial (RCT) ...
Status
Active Not Recruiting
Location
Kaiser Permanente-Downey Medical Center
Start Date
2017-02-15
Trial ID
NCT02875353
Treatments Being Tested
Background: Drug resistant tuberculosis is a serious public health problem...
Status
Unknown
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02776150
This study will be the first repeat dose administration of GSK1322322 to in...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-11
Trial ID
NCT00896558
Treatments Being Tested